the aid library

Filter

792

Africa CDC Event-based Surveillance Resources

Africa Center for Disease Control and Prevention CDC (2023) CC

2nd edition. The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing event-based surveillance (EBS) using a multisectoral, One Health appr ... more

Optimizing active case-finding for tuberculosis

World Health Organization. Regional Office for South-East Asia (2021) C_WHO

he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv ... more

Best Practices and Experience of Mauritius Preparedness and Response to COVID-19 Pandemic

World Health Organization WHO; Regional Office for Africa, Government of Mauritius (2021) C_WHO

his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide ... more

Water, sanitation and hygiene in health care facilities: practical steps to achieve universal access to quality care

World Health Organization WHO; UNICEF (2019) C_WHO

Safe Abortion Care During Infectious Disease Outbreaks: Supplemental Guidance for Humanitarian and Fragile Settings

Inter-agency Working Group on Reproductive Health in CrisesInternational Rescue Committee (2023) CC

The purpose of this guide is to provide practical advice for health staff undertaking infectious disease preparedness and response activities to ensure that access to safe abortion care (SAC) is maintained when an infectious disease outbreak occurs. It is an operational guide which can serve to supp ... more

Community Perspectives about Ebola in Bong, Lofa and Montserrado Counties of Liberia: Results of a Qualitative Study

Najmeh Modarres; Sekou W. Konneh USAID; John Hopkins University; Health Communication Capacity Collaborative, et al. (2015)

Inclusion made easy in eye health programs

Christoffel-Blinden Mission (CBM) Christoffel Blinden Mission (CBM) (2015) CC

Disability inclusive practices for strengthening comprehensive eye care

Mental Health in the Asia-Pacific Region: An Overview

Alexander Lourdes Samy, Zahra Fazli Khalaf, & Wah-Yun Low International Journal of Behavioral Science (2015) CC

Mental health problem is one of the growing major public health issues in the Asia Pacific region. It contributes to the high number of Disability Adjusted Life Years (DALYs), morbidity and mortality in the region. It is expected that leading mental health problems will occur in the low-and middle-i ... more

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

E. J. Abrams; J. Ananworanich; M. Archary; M.N. Ngongondo; P. Brouwers J Acquir Immune Defic Syndr; Pub Med (2018) C2

J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

Let our actions count - South African's national strategic plan for HIV; TB and StIs 2017-2022

South African Government; NDP 2030; South African National AIDS council (our Action count) (2019) C2

Accessed: 21.10.2019

Integrated Care for Older People (ICOPE) - A manual for primary care physicans - Trainee´s handbook

World Health Organization WHO (2020) C_WHO

The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physicians who will provide care to older people in primar ... more

Antimicrobial Resistance: Challenges and Perspectives

Doyle, M.P.; G. H. Loneragan, H. M. Scott et al. (2006) C2

Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248 In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientiﬁc knowledge pe ... more

Response to the Ukraine Crisis: interim report, February to June 2022

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov ... more

Sierra Leone: National Community Health Worker Policy 2016–2020

Ministry of Health and Sanitation of Sierra Leone (2016) C1

EMTCT Plus - Framework for Elimination of Mother-to-Child Transmission of HIV, Syphilis, Hepatitis B, and Chagas

F. Pérez; M. B. Mello; L. Sereno; Pan American Health Organization; World Health Organization (2017) C_WHO

The objective of the EMTCT Plus initiative is to achieve and sustain the elimination of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis B (HBV) as a public health threat. It embraces the principles and lines of action of the Strategy for Universal Access to Health a ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Social determinants of mental health

Fundação Calouste Gulbenkian World Health Organization WHO (2014) C_WHO

Good mental health is integral to human health and well being. A person’s mental health and many common mental disorders are shaped by various social, economic, and physical environments operating at different stages of life. Risk factors for many common mental disorders are heavily associated wit ... more

HIV and AIDS in India

Avert (2018) C2

Hospital Readiness Checklist for COVID-19

World Health Organization (Europe) (2020) C_WHO

Interim Version 24, February 2020 This checklist has been prepared with the aim of supporting hospital managers and emergency planners in achieving the above by defining and initiating actions needed to ensure a rapid response to the COVID-19 outbreak. The checklist is structured on eleven key co ... more

Health system considerations: when influenza meets COVID-19: preparedness and response measures when COVID-19, influenza and acute respiratory infections coincide in the WHO European Region

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

revised version December 2020